Nymox Pharmaceutical Leads with Innovative Alzheimer's Disease Programs
29-Aug-2002
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
Transmission routes of spreading protein particles - Study on cell cultures gives insights into the mechanisms of neurodegenerative diseases
Go to page
Methacholine
Go to page
Fritz Schorfmann Ges.mbH & Co KG - Grasberg, Germany
Go to page
Fritz Massong GmbH - Frankenthal, Germany
Go to page
Decisive steps in the initiation of programmed cell death revealed - Tübingen researchers have studied the formation of membrane pores that are critical to start the apoptosis program
Go to page
First treatment for muscular dystrophy in sight: Scientists successfully harness exon-skipping
Go to page
Onxeo announces positive DSMB recommendation for its Phase III trial with Livatag in primary liver cancer
Go to page
Horizon Discovery Receives the Queen’s Award for Enterprise in International Trade
Go to page
Immunity drives cancer into permanent growth arrest
Go to page